Evidence map›Paper›PMID 34265035›Full record

ReviewAdvances in nutrition (Bethesda, Md.)2021

Perspective: Moving Toward Desirable Linoleic Acid Content in Infant Formula.

Susan E Carlson, Lidewij Schipper, J Thomas Brenna, Carlo Agostoni, Philip C Calder, Stewart Forsyth, Philippe Legrand, Marieke Abrahamse-Berkeveld, Bert J M van de Heijning, Eline M van der Beek and 2 more

Open access · hybridAbstract readReview
In one paragraph

Review in Advances in nutrition (Bethesda, Md.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Dietary Fatty Acids and Inflammation: Focus on the n-6 Series.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 7 countries.

Susan E CarlsonDepartment of Dietetics and Nutrition, Kansas University Medical Center, Kansas City, KS, USA.ORCID 0000-0003-3579-1685
Lidewij SchipperDanone Nutricia Research, Utrecht, The Netherlands.
J Thomas BrennaDepartment of Pediatrics, University of Texas at Austin, Austin, TX, USA.
Carlo AgostoniPediatric Area, Fondazione IRCCS Ca'Granda- Ospedale Maggiore Policlinico, Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0002-5006-0832
Philip C CalderFaculty of Medicine, University of Southampton, Southampton, United Kingdom.
Stewart ForsythUniversity of Dundee, West Ferry, Dundee, United Kingdom.
Philippe LegrandLaboratoire de Biochimie-Nutrition Humaine, Agrocampus-French National Institute of Health and Medical Research, Rennes, France.
Marieke Abrahamse-BerkeveldDanone Nutricia Research, Utrecht, The Netherlands.
Bert J M van de HeijningDanone Nutricia Research, Utrecht, The Netherlands.
Eline M van der BeekDanone Nutricia Research, Utrecht, The Netherlands.
Berthold V KoletzkoLudwig-Maximilians-Universität Munich, Department of Paediatrics, Dr von Hauner Children's Hospital, University of Munich Medical Center, Munich, Germany.
Beverly MuhlhauslerNutrition and Health Program, Health and Biosecurity, CSIRO, Adelaide, Australia.
Danone (Netherlands) · NLCornell University · USCSIRO Health and Biosecurity · AUInstitut Agro Rennes-Angers · FRLudwig-Maximilians-Universität München · DEUniversity Medical Center · USUniversity Medical Center Groningen · NLUniversity of Dundee · GBUniversity of Milan · ITUniversity of Southampton · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infant formula should provide the appropriate nutrients and adequate energy to facilitate healthy infant growth and development. If conclusive data on quantitative nutrient requirements are not available, the composition of human milk (HM) can provide some initial guidance on the infant formula composition. This paper provides a narrative review of the current knowledge, unresolved questions, and future research needs in the area of HM fatty acid (FA) composition, with a particular focus on exploring appropriate intake levels of the essential FA linoleic acid (LA) in infant formula. The paper highlights a clear gap in clinical evidence as to the impact of LA levels in HM or formula on infant outcomes, such as growth, development, and long-term health. The available preclinical information suggests potential disadvantages of high LA intake in the early postnatal period. We recommend performing well-designed clinical intervention trials to create clarity on optimal levels of LA to achieve positive impacts on both short-term growth and development and long-term functional health outcomes.

Indexed as

Infant FormulaLinoleic AcidHumansInfantInfant Nutritional Physiological PhenomenaMilk, HumanNutritional RequirementsLinoleic Acidhuman milk compositioninfant developmentinfant formulaLCPUFAslinoleic acidnutritional programming

Identifiers

PMID34265035
PMCPMC8634410
OpenAlexW3174610032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.